Overall, A223 model demonstrates a detectable level of heterogeneity during spontaneous anti-tumor immune responses, although it remains unknown whether and how ICI treatment affects CD8 TIL TCR repertoires in A223 model. This evidence concerns the gene CD8A and neoplasm.